---
document_datetime: 2023-09-21 17:21:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_en.pdf
document_name: nuedexta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7857161
conversion_datetime: 2025-12-28 04:11:49.196432
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength     | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|--------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/13/833/001  | Nuedexta          | 15 mg / 9 mg | Capsule, hard         | Oral use                  | bottle (HDPE)         | 60 capsules |
| EU/1/13/833/002  | Nuedexta          | 15 mg / 9 mg | Capsule, hard         | Oral use                  | blister (PVC/alu)     | 13 capsules |
| EU/1/13/833/003  | Nuedexta          | 23 mg / 9 mg | Capsule, hard         | Oral use                  | bottle (HDPE)         | 60 capsules |

<!-- image -->